Pfizer Biosimilars And Anti-Infectives Get Higher Profile Under New Structure

Pfizer will reorganize from two business units to three, creating a separate Consumer Healthcare unit alongside Innovative Medicines and Established Medicines. The changes will not be effective until the beginning of 2019.